Myth-Busting is Still Alive: FAR Council Encourages Industry/Government Communications
Client Alert | 1 min read | 12.02.16
To implement section 887 of the FY 2016 National Defense Authorization Act, the FAR Council, on November 29, proposed a rule to amend FAR 1.102-2 by adding language to clarify that the government may, and is encouraged to, communicate with industry as part of market research, if such exchanges comport with existing law and regulations and do not further an unfair competitive advantage. Continuing the conversation that the 2011 and 2012 Office of Federal Procurement Policy Myth-Busting memoranda commenced, the Council also requested suggestions about ways to “further enhance open communication between industry and the Federal acquisition community[,]” as well as information responding to specific questions – responses to which are due on or before January 30, 2017 (the same due date for submitting comments on the proposed rule).
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
